Sign in Subscribe
Coronaviruses

COVID-19 Pandemic Affects Hemoptysis Management, According to New Research

Strategic Insights

— 1 min read

A new study conducted by researchers at the University of Health Sciences Turkiye has investigated the impact of the COVID-19 pandemic on hemoptysis management. The study, published in the Hamidiye Medical Journal, aimed to determine whether there was a difference in the frequency of hospitalizations due to hemoptysis during the pandemic period compared to the pre-pandemic period. The research found that there was no significant difference in the frequency of hospitalizations due to hemoptysis during the pandemic period, but the decrease in all hospitalizations during the pandemic period was 30.0%, and the decrease in hemoptysis-related hospitalizations was 20.4%.

Key Takeaways:

  • The study was a retrospective, observational, cross-sectional analysis of patients hospitalized for hemoptysis during the pre-pandemic (March 11, 2019-March 10, 2020) and pandemic (March 11, 2020-March 10, 2021) periods.
  • The hospitalization rate due to hemoptysis was 1.9% in the pre-pandemic group and 2.2% in the pandemic group, with a p-value of 0.07.
  • The decrease in the rate of hospitalization for all reasons was 30.0%, and the decrease in the rate of hospitalization for hemoptysis was 20.4% (p < 0.05).
  • The research concluded that there was no significant difference in the frequency of hospitalizations due to hemoptysis during the pandemic period, but the decrease in all hospitalizations was lower for hemoptysis-related hospitalizations.
  • The study's findings suggest that the emergency nature of hemoptysis and the presence of patients with COVID-19 in the pandemic group may have contributed to the observed trends.
  • The proportion of idiopathic cases and etiological causes remained similar during both periods, indicating a consistent approach to hemoptysis management.

Statistics:

  • 1.9% of patients in the pre-pandemic group were hospitalized due to hemoptysis.
  • 2.2% of patients in the pandemic group were hospitalized due to hemoptysis.
  • The hospitalization rate decreased by 30.0% overall during the pandemic period.
  • The hospitalization rate for hemoptysis decreased by 20.4% (p < 0.05).
  • The p-value for the comparison of the two groups was 0.07.

Sources:

  • Is There Any Difference Between Pandemic and Pre-Pandemic Periods in Hemoptysis Management? Hamidiye Medical Journal, 2025,6(3):135-143.
  • NewsRx. Data on COVID-19 Described by Researchers at University of Health Sciences Turkiye (Is There Any Difference Between Pandemic and Pre-Pandemic Periods in Hemoptysis Management?). Medical Letter on the CDC & FDA. November 2, 2025; p 315.

Read more